IP University Receives PCI Approval for New Pharmacy Courses

IP University's new pharmacy courses will be run under the Centre of Excellence in Pharmaceutical Sciences (CEPS) and will first introduced on the university campus.

Guru Gobind Singh Indraprastha University (GGSIPU) has received approval for new pharmacy courses from the Pharmacy Council of India (PCI) from academic session 2024-25 academic session. PCI is the statutory body under the Ministry of Health and Family Welfare, Government of India and is responsible for the regulation of pharmacy education in India. 

The IPU new courses in 2024 include DPharm, Bhparm, and MPharm in pharmacology, pharmaceutics, phytopharmacy and phytomedicine and pharmaceutical chemistry with a seat intake of 220 seats overall. These courses will cater to the need for qualified manpower in the pharmaceutical sector.

Initially, these courses will be introduced on the university campus and will be run under the Centre of Excellence in Pharmaceutical Sciences (CEPS). As of now, CEPS is offering only two PG programmes namely MSc in Medicinal Chemistry and Drug Design and MSc in Bioinformatics and PhD programmes in Pharmaceutical Chemistry.

Key Details

Additional Information

1. These new programs will be offered under the Centre of Excellence in Pharmaceutical Sciences (CEPS).
2. This is the first time these programs will be available on the university campus.
3. The total intake for these programs is 220 students.
4. Admission criteria for each program may vary.

Reportedly, the DPharm programme will have an intake of 60 seats, BPharm will admit 100 students and MPharm in pharmaceutics, pharmacology, phytopharmacy and phytomedicine and pharmaceutical chemistry will have 15 seats each, as reported by Indian Express.

IP University Pharmacy Course Admission Criteria 2024

The DPharm admission will be offered based on merit in the qualifying class 12 exam while admission to BPharm will first based on IPU CET scores and the remaining seats will be offered based on NEET scores. Besides, admission to MPharm programmes will be first provided to the GPAT-qualified candidates followed by CET applicants. 

Frequently Asked Question 

Ques: What is IP University?

Ans: IP University, also known as Guru Gobind Singh Indraprastha University (GGSIPU), is a public state university located in Delhi, India. It offers a wide range of undergraduate, postgraduate, and doctoral programs across various disciplines.

Ques: What does PCI approval mean?

Ans: PCI stands for the Pharmacy Council of India. PCI approval signifies that a program meets the standards and guidelines set by the council, ensuring quality education and training in the field of pharmacy.

Ques: Which new programs at IP University have received PCI approval?

Ans: The specific new programs that have received PCI approval will be listed in the official announcement by IP University. Typically, these programs include new undergraduate and postgraduate courses in pharmacy and related fields.

Ques: Why is PCI approval important for new pharmacy programs?

Ans: PCI approval is crucial as it ensures that the programs adhere to national standards for pharmacy education. It also allows graduates of these programs to be eligible for licensure and practice as pharmacists in India.

Ques: How will the new PCI-approved programs benefit students at IP University?

Ans: Students will benefit from high-quality education and training that meets national standards, increased job prospects, and eligibility for professional licensure. Additionally, these programs can enhance the university's reputation and attract more students.